Canada
· Delayed Price · Currency is CAD DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of CAD 32.35 million. The enterprise value is 33.11 million.
| Market Cap | 32.35M |
| Enterprise Value | 33.11M |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DIAGNOS has 95.15 million shares outstanding. The number of shares has increased by 8.97% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 95.15M |
| Shares Change (YoY) | +8.97% |
| Shares Change (QoQ) | +5.61% |
| Owned by Insiders (%) | 5.86% |
| Owned by Institutions (%) | n/a |
| Float | 89.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 170.77 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.87 |
| EV / Sales | 215.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.31 |
Financial Position
The company has a current ratio of 1.09
| Current Ratio | 1.09 |
| Quick Ratio | 1.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.31 |
| Interest Coverage | -4.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -92.32% |
| Return on Capital (ROIC) | -127.53% |
| Revenue Per Employee | 6,977 |
| Profits Per Employee | -152,491 |
| Employee Count | 22 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.63% in the last 52 weeks. The beta is -0.56, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.56 |
| 52-Week Price Change | -5.63% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.32 |
| Relative Strength Index (RSI) | 56.27 |
| Average Volume (20 Days) | 225,402 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of CAD 153,491 and -3.35 million in losses. Loss per share was -0.04.
| Revenue | 153,491 |
| Gross Profit | -796,474 |
| Operating Income | -2.81M |
| Pretax Income | -3.35M |
| Net Income | -3.35M |
| EBITDA | -2.78M |
| EBIT | -2.81M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 2.49 million in cash and 3.25 million in debt, giving a net cash position of -760,626 or -0.01 per share.
| Cash & Cash Equivalents | 2.49M |
| Total Debt | 3.25M |
| Net Cash | -760,626 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -914,660 |
| Book Value Per Share | -0.01 |
| Working Capital | 227,680 |
Cash Flow
In the last 12 months, operating cash flow was -2.48 million and capital expenditures -10,689, giving a free cash flow of -2.49 million.
| Operating Cash Flow | -2.48M |
| Capital Expenditures | -10,689 |
| Free Cash Flow | -2.49M |
| FCF Per Share | -0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,828.68% |
| Pretax Margin | -2,185.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.97% |
| Shareholder Yield | -8.97% |
| Earnings Yield | -12.80% |
| FCF Yield | -7.69% |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -24.6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.6 |
| Piotroski F-Score | n/a |